Home
Mark Andrew Wilson, Chief Legal Officer: Nektar Therapeutics NKTR Sell · Filed 25/11/25
Trade details
- Type
- Insider sale
- Amount
- $34,196.4
- Shares · price
- 630 sh · $54.28 a share
- Held after
- 21,585 sh
- Trade date
- 25/11/25
- Filed
- 25/11/25
- Days to filing
- 0 days
Sold 2.8% of holdings
- Share of holding sold
- 2.8%
Nektar Therapeutics trades, last 26 weeks
What else happened in Nektar Therapeutics around then
Filed or reported within 30 days of the trade day · 25/10/26~25/12/25Mark Andrew Wilson's recent trades
- Mark Andrew Wilson
Planned saleNektar Therapeutics
Planned saleNektar Therapeutics
NKTR
$5.7M
78,510 sh
$5.7M
Filed 03/13
Traded 03/13
- Mark Andrew Wilson
Planned saleNektar Therapeutics
Planned saleNektar Therapeutics
NKTR
$37.1K
630 sh
$37.1K
Filed 25/11/25
Traded 25/11/25
- Mark Andrew Wilson
SellNektar Therapeutics
SellNektar Therapeutics
NKTR
$18K
676 sh
$18K
Filed 25/08/21
Traded 25/08/19
- Mark Andrew Wilson
Planned saleNektar Therapeutics
Planned saleNektar Therapeutics
NKTR
$18K
676 sh
$18K
Filed 25/08/19
Traded 25/08/19
- Mark Andrew Wilson
SellNektar Therapeutics
SellNektar Therapeutics
NKTR
$6,697
9,996 sh
$6,697
Filed 25/05/21
Traded 25/05/19